Peter Schirmacher
Peter Schirmacher
Professor für Pathologie, Universitätsklinik Heidelberg
Verified email at
Cited by
Cited by
The 2019 WHO classification of tumours of the digestive system
ID Nagtegaal, RD Odze, D Klimstra, V Paradis, M Rugge, P Schirmacher, ...
Histopathology 76 (2), 182, 2020
EASL clinical practice guidelines: management of hepatocellular carcinoma
PR Galle, A Forner, JM Llovet, V Mazzaferro, F Piscaglia, JL Raoul, ...
Journal of hepatology 69 (1), 182-236, 2018
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
TW Kang, T Yevsa, N Woller, L Hoenicke, T Wuestefeld, D Dauch, ...
Nature 479 (7374), 547-551, 2011
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ...
Annals of oncology 29, iv238-iv255, 2018
Most pancreatic cancer resections are R1 resections
I Esposito, J Kleeff, F Bergmann, C Reiser, E Herpel, H Friess, ...
Annals of surgical oncology 15, 1651-1660, 2008
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Nunez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...
Nature 592 (7854), 450-456, 2021
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients …
SE Al-Batran, RD Hofheinz, C Pauligk, HG Kopp, GM Haag, KB Luley, ...
The lancet oncology 17 (12), 1697-1708, 2016
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma …
A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ...
Journal of clinical oncology 30 (13), 1438-1446, 2012
Peginterferon alpha‐2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
K Wursthorn, M Lutgehetmann, M Dandri, T Volz, P Buggisch, B Zollner, ...
Hepatology 44 (3), 675-684, 2006
Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy
A Mehrabi, A Kashfi, H Fonouni, P Schemmer, BM Schmied, P Hallscheidt, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma
H Varnholt, U Drebber, F Schulze, I Wedemeyer, P Schirmacher, ...
Hepatology 47 (4), 1223-1232, 2008
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment
S Reiss, I Rebhan, P Backes, I Romero-Brey, H Erfle, P Matula, L Kaderali, ...
Cell host & microbe 9 (1), 32-45, 2011
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer
L Zender, W Xue, J Zuber, CP Semighini, A Krasnitz, B Ma, P Zender, ...
Cell 135 (5), 852-864, 2008
Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation
AR Choudhury, Z Ju, MW Djojosubroto, A Schienke, A Lechel, ...
Nature genetics 39 (1), 99-105, 2007
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K Breuhahn, T Longerich, P Schirmacher
Oncogene 25 (27), 3787-3800, 2006
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy
N Halama, S Michel, M Kloor, I Zoernig, A Benner, A Spille, ...
Cancer research 71 (17), 5670-5677, 2011
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development
M Eißmann, T Gutschner, M Hämmerle, S Günther, M Caudron-Herger, ...
RNA biology 9 (8), 1076-1087, 2012
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
AH Scheel, M Dietel, LC Heukamp, K Jöhrens, T Kirchner, S Reu, ...
Modern Pathology 29 (10), 1165-1172, 2016
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop
R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ...
Journal of Thoracic Oncology 5 (10), 1706-1713, 2010
TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis
S Kanzler, AW Lohse, A Keil, J Henninger, HP Dienes, P Schirmacher, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 276 (4 …, 1999
The system can't perform the operation now. Try again later.
Articles 1–20